Submitted by Marijuana News on Tue, 10/08/2019 – 10:38
China has a zero tolerance approach to marijuana (along with numerous other drugs), yet surprisingly it is the world’s largest producer of hemp, and also the world’s largest exporter of this increasingly lucrative plant.
While chances of medical marijuana being legalized in China are seemingly next to none, calls for a clear policy when it comes to industrial hemp and CBD products are increasing — as is the plant’s production in the country.
While cannabidiol (CBD) has become as widely proliferated as over-the-counter painkillers in the West, products using this hemp-derived compound have yet to be seen stocking store shelves in China. The plant it originates from, however, has had a far lengthier history. Ma (麻), the Chinese word for hemp, has actually been in use for thousands of years, widely enough that the classic text Book of Odes, or Shi Jing (诗经), contains many references to hemp use in the daily lives of Chinese people from the 11th to 7th century BCE.
The cultivation of hemp was made illegal in 1985, despite China having a long history with the crop. It was only in 2010, after a push by locals, that authorities again allowed it to be grown on an industrial scale in Yunnan province in southwest China.
Marijuana plants containing the psychoactive agent tetrahydrocannabinol (THC) are to date resoundingly illegal within China — despite what Randy from South Park might think — but plants containing quantities of CBD fall into a grayer area.
As it stands, companies are allowed to farm industrial hemp in Heilongjiang and Yunnan provinces (in China’s northeast and southwest respectively). China Daily reported early this year that talk of farmers being allowed to grow industrial hemp in Jilin province (next door to Heilongjiang), which had begun in 2017, had proven fruitful. Additional sources attest that hemp is also legally being grown in regions such as Anhui, Gansu, and Xinjiang.
Figures provided on Hanma Industrial Group Co. Ltd.’s website — one of China’s leading hemp producers — show that half a million hectares of land were used to grow hemp in Anhui province, close to Shanghai in eastern China, in 2014. Other provinces, excluding Heilongjiang and Yunnan, accounted for 0.4 million hectares. Curiously, many media outlets fail to report these facts.
This confusion as to the location of hemp farms in the country is perhaps related to the distinctions of industrial hemp. Industrial hemp is a marijuana plant (cannabis sativa L. subsp. sativa var. sativa) specifically bred to contain the least amount of THC possible, and has a wide range of applications. Industrial hemp is the most commonly farmed hemp strain, although China is home to hemp plants from 33 families and more than 90 genera, including ramie, flax, jute, kenaf, sisal hemp, and abaca.
With that being said, police have historically targeted marijuana plants grown outside of the industry complex. This year, for instance, authorities eradicated 10,000 wild plants growing alongside the Yongding river in Beijing’s Fengtai district.
The mood at the Industrial Cannabis Forum of Listed Companies in mid-August was pragmatic in the face of such continued confusion over regulations in the industry. Participants called for more clearly defined policies on the issues, while Yuan Hua, general manager of Kunming Pharmaceutical Group, said that China’s cannabis industry will need an additional two to three years’ time to establish itself. Her suggestion for companies in the meantime was “research and development,” in order to create new pharmaceuticals and products and lay the groundwork for the future of the industry.
With the recent rise in products containing CBD around the globe, Chinese hemp farmers and companies have begun to turn their attention to cosmetics, pharmaceuticals, beverages, and other products that use CBD in some form.
Tan Xin, chairman and founder of Hanma Investment Group Co. Ltd., tells us: “We did a lot of research in the early days and saw that investors like Peter Thiel and George Soros had put money into this industry. We believe this business has huge potential.”
As an example of the potential lucrative nature of this industry, consider that July to late September/early October is usually harvesting season for hemp plants in China. As more companies seek to gain a foothold in this fledgling market — and news of developments like the legalization of industrial hemp farming in Jilin province has spread — stock prices for firms such as Dezhan Health and Meiyingsen have soared this year not only during harvest time, but since the beginning of 2019, prompting international media outlets like The New York Times to sit up and take notice.
Yet in a move that perhaps put a damper on the industry, the Chinese National Anti-Drug Committee published a release in mid-March earlier this year re-clarifying the country’s stance on industrial hemp farming. The release plainly stated that CBD is not included on the list of narcotic drugs in the country, and that it is not a controlled drug. It also stated that marijuana with a THC content of 0.3% or less can be grown in certain parts of China. While this release certainly clarified parts of China’s stance on CBD, it was also vague in many areas and had a negative effect on multiple stocks on Chinese exchanges, prompting investors to sell off.
Nonetheless, people like Tan are optimistic about the future of CBD in the country, particularly in the beauty industry. “Nowadays, CBD is considered an ‘all-purpose ingredient’ [for beauty] in the Western world,” says Tan. “It not only has a therapeutic effect on skin diseases, but is also effective in terms of oil control, acne, and skin whitening.
While research and development for all types of products using CBD is technically legal, only beauty products with CBD are legal to sell in China.
“Since 2015, ‘hemp leaf extraction’ can be legally used in cosmetics,” says Tan. “And because the cosmetics industry is so huge in China, we have a good shot in this business.”
He adds however that pharmaceuticals and health products remain the company’s biggest priority at the moment.
All of this points to the crux of China’s argument for the widespread legalization of industrial hemp farming and CBD use in medicine: health.
Many tout the benefits of CBD in treating conditions like epilepsy and Alzheimer’s, as well as providing pain relief, though research on some of these claims is as of yet inconclusive. According to a report by Global Times, China holds 309 of the world’s 606 hemp-related patents, but due to legal restrictions, Chinese-made food and medicine containing CBD can only find a market outside of the country, in places like the US and the EU.
As Tan puts it, “the hemp industry is a health industry. Nothing will keep us from the pursuit of health.”
Authored By: Radii China
For Immediate Release
September 18, 2019
General Assembly’s 2020 session to begin Jan. 7
FRANKFORT – The schedule for the 2020 Regular Session of the Kentucky General Assembly was approved today by legislative leaders.
The session is scheduled to convene on Jan. 7 and adjourn April 15. It is expected to last 60 legislative days – the maximum allowed by the state constitution in even-numbered years.
Lawmakers will not convene on Jan. 20 in observance of Martin Luther King, Jr. Day or on Feb. 17 in observance of Presidents’ Day.
March 2 will be the final day that House bills can be introduced and March 3 will be the final day for the introduction of Senate bills. Bills that have been introduced by these deadlines will be able to continue moving through the legislative process until the session adjourns.
The veto recess – the period of time in which lawmakers return to their home districts to await possible gubernatorial vetoes of legislation – will run from April 2-13. Lawmakers will return to the Capitol on April 14 and 15 for the final two days of the session.
To view the calendar online, go to: https://legislature.ky.gov/Documents/20RS_Calendar.pdf.
Kentucky Heligen 24(c) Request Approved; Can Help Control Corn Earworm, Cotton Bollworm, and Tobacco Budworm
Heligen, manufactured by AgBiTech Pty Ltd, can now be used on industrial hemp in Kentucky to aid in control of corn earworm, cotton bollworm and tobacco budworm.
This has been accomplished through a Special Local Needs (SLN) 24(c) request submitted by the Kentucky Department of Agriculture (KDA) to the EPA.
Use of Heligen (EPA Registration No.: 87978-2) is approved through December 31, 2024 unless the SLN is otherwise amended, withdrawn, canceled or suspended.
Hemp producers are responsible for determining which pesticides can be used and in what manner.
KDA encourages growers to work with processors or purchasers on what will be acceptable before applying this or any product. Heligen also will be added to KDA’s online list of Pesticide Products Registered for Industrial Hemp in Kentucky.
Industrial Hemp Program Manager
Department of Agriculture
Office of Marketing
111 Corporate Drive
Frankfort, KY 40601
For Immediate Release
FRANKFORT (Sept. 27, 2019) – Kentucky hemp growers and processors may apply for a hemp license from the Kentucky Department of Agriculture’s (KDA) hemp program for 2020 beginning November 15, Agriculture Commissioner Ryan Quarles announced.
“We are constantly looking for ways to improve our hemp program,” Commissioner Quarles said. “We are making significant changes to the application process for the 2020 growing season to make it work better for Kentucky’s growers and processors. 2019 will be a record-breaking year for Kentucky’s hemp program, and we expect continued growth in 2020.”
Among the major application changes in 2020:
- KDA will accept grower applications from November 15, 2019, to March 15, 2020.
- KDA will accept processor/handler applications beginning on November 15, 2019.
- The KDA will host an online application on its hemp webpage, kyagr.com/hemp.
- The new online application will include a mapping function.
“Kentucky continues to be the tip of the spear on restoring this crop, but I always remind folks that we are still in the infancy of the restoration. Challenges persist, ranging from federal uncertainty regarding cannabinol to banking and lending issues,” Commissioner Quarles said. “Any business venture – especially in a new industry – carries risk, and the hemp industry is no exception. It is important that our growers and processors remain clear-eyed about the opportunities and challenges ahead of us in the years to come.”
For those interested in learning more about Kentucky’s hemp program, KDA will host a Kentucky Hemp Summit for growers, processors, and other interested parties on December 4, 2019, at the Kentucky Exposition Center in Louisville.
The 2018 Farm Bill removed industrial hemp from the federal Controlled Substances Act, gave hemp growers increased access to USDA programs, and outlined the minimum requirements a state regulatory framework must contain to earn approval by the U.S. Department of Agriculture (USDA). The federal Risk Management Agency announced in August that certain hemp growers may obtain insurance coverage under the Whole-Farm Revenue Protection Program in 2020.
For more information about KDA’s hemp research pilot program, go to kyagr.com/hemp .
PLEASE PLAN TO ATTEND THIS VERY IMPORTANT PICNIC AND MEETING FOR ALL THOSE KENTUCKIANS WHO FEEL VERY LET DOWN BY THE CURRENT BEVIN ADMINISTRATION!
IT WILL BE HELP ON SEPTEMBER 28, 2019 (SATURDAY), AT THE HOME OF SENATOR DAN SEUM, LOCATED AT:
1107 HOLLY AVENUE, FAIRDALE, KENTUCKY 40118
PLEASE FOLLOW THE LINK TO THE FACEBOOK EVENT FOR MORE INFORMATION!
THIS PICNIC IS FOR ALL OF US! (EXCEPT MR. BEVIN)
Above: Please view the promotional video for the picnic with Sen. Dan Seum!
Remember when Bevin said, “I guarantee you somewhere in Kentucky today a child was sexually assaulted that was left at home because there was nobody there to watch them.”? There also was mention of children trying drugs for the first time that day.
Remember when Bevin blamed the shooting of a 7 year old on a sickout?
Remember when Bevin was running for Governor the first time and he promised he would fight to get cannabis for those needing it. Then after getting elected he said legalizing marijuana creates homelessness, fills up ERs and isn’t a realistic option for Kentucky.
Remember Bevin claiming he would sign a medical marijuana bill during the 2019 legislative session knowing his current running mate wouldn’t allow it to be heard.
Remember when Bevin bought a $2.9 million property for $1.6 million from his friend, Neil Ramsey, who happened to also donate to his political campaign and be an investor in his company. Did I mention that Ramsey was then appointed to the Kentucky Retirement System Board of Trustees by Bevin? Did I also mention that the appraiser on that property is named John May. Bevin appointed May’s wife, Shellie May, as executive director of the Kentucky Commission of Children with Special Health Care Needs.
Remember when Bevin was the least popular governor in the US?
Remember when Bevin compared teachers to thugs and called us selfish and ignorant?
Remember when Bevin said, “It’s just straight up about wanting more than your fair share,” as he compared teachers to people who hoarded rationed goods during WWII?
Remember when Bevin said teachers and state workers weren’t sophisticated enough to really understand the pension bill?
Remember when Bevin took $201.5 million from the Kentucky Employees’ Health Plan to balance the budget?
Remember when he called high court justices incompetent?
Remember when Bevin intentionally withheld the actuary analysis that revealed that the retirement system would be fully funded by 2043 if it was unchanged but continued to be fully funded?
Remember when Bevin called our students “soft” because our school districts didn’t want kids to be outside in sub zero arctic temperatures?
Remember when Al Roker called him a nitwit?
Remember when Bevin hired his friend, Grindle, and then raised his salary from $160,000 to $375,000? That’s a $215,000 raise.
Remember when Bevin got elected and he reversed the states decision to raise the minimum wage.
Remember when Bevin’s Labor Cabinet said they will fine teachers $1000 for protesting?
Remember when Bevin approved SB 151 that deleted a $5,000 life insurance death benefit from police, fire fighters, teachers, and other state workers?
Remember when Bevin called a special session in December 2018 that wasted tax payers money to accomplish nothing.
Remember when he continues to try to call a special session this year, but doesn’t have the votes?
Remember when Bevin said it’s none of the tax payers business why he uses a plan owned by the tax payers.
Remember when Bevin’s running mate became the first ever African-American woman to hold an executive office in the state of Kentucky, to then be dumped when he ran for a second term?
Remember when Bevin publicly applauded the University of Kentucky’s men’s basketball team for advancing to the Elite 8, but said nothing about University of Louisville’s women’s team who did the same thing?
Remember when Bevin said the West Louisville chess club at Nativity Academy is ‘not something you necessarily would have thought of when you think of this section of town.’?
Remember when he proudly boasted about making all of his children contract chicken pox?
Remember when Bevin said, “It’s like saving a drowning victim, Brian. It’s like somebody — they’re fighting you, biting you, pulling you under. You just need to knock them out and drag them to shore. It’s for their own good and we have to save the system,” when talking about teachers who opposed to his pension plan.
Remember when Bevin said that teachers hoard sick days?
Remember when Bevin attended the Kentucky Derby and while an interview was occurring next to him on national television about the death of a trainer, he continued to be on his phone?
Remember when Bevin was late paying his property taxes?
Remember when Bevin cut dental and vision benefits for 460,000 Medicaid recipients?
Remember when people who don’t even live in Kentucky contacted you about something embarrassing Bevin had done or said that made it on national news coverage?
Remember when Bevin says, “We are Kentucky,” at the end of every speech, but he isn’t even from Kentucky?
This list could continue on…
Just in case you need a REMINDER on why NOT to vote for
Mr. Bevin . . .
FOR IMMEDIATE RELEASE
Monday, August 26, 2019
DEA Announces Steps Necessary to Improve Access to Marijuana Research
The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering additional qualified marijuana growers will increase the variety of marijuana available for these purposes.
Over the last two years, the total number of individuals registered by DEA to conduct research with marijuana, marijuana extracts, derivatives and delta-9-tetrahydrocannabinol (THC) has increased by more than 40 percent from 384 in January 2017 to 542 in January 2019. Similarly, in the last two years, DEA has more than doubled the production quota for marijuana each year based on increased usage projections for federally approved research projects.
“I am pleased that DEA is moving forward with its review of applications for those who seek to grow marijuana legally to support research,” said Attorney General William P. Barr. “The Department of Justice will continue to work with our colleagues at the Department of Health and Human Services and across the Administration to improve research opportunities wherever we can.”
“DEA is making progress in the program to register additional marijuana growers for federally authorized research, and will work with other relevant federal agencies to expedite the necessary next steps,” said DEA Acting Administrator Uttam Dhillon. “We support additional research into marijuana and its components, and we believe registering more growers will result in researchers having access to a wider variety for study.”
This notice also announces that, as the result of a recent amendment to federal law, certain forms of cannabis no longer require DEA registration to grow or manufacture. The Agriculture Improvement Act of 2018, which was signed into law on Dec. 20, 2018, changed the definition of marijuana to exclude “hemp”—plant material that contains 0.3 percent or less delta-9 THC on a dry weight basis. Accordingly, hemp, including hemp plants and cannabidiol (CBD) preparations at or below the 0.3 percent delta-9 THC threshold, is not a controlled substance, and a DEA registration is not required to grow or research it.
Before making decisions on these pending applications, DEA intends to propose new regulations that will govern the marijuana growers program for scientific and medical research. The new rules will help ensure DEA can evaluate the applications under the applicable legal standard and conform the program to relevant laws. To ensure transparency and public participation, this process will provide applicants and the general public with an opportunity to comment on the regulations that should govern the program of growing marijuana for scientific and medical research.
The Notice of Application is available here: https://www.federalregister.gov/public-inspection/current.
Press Release Number:
Updated August 26, 2019
More than six months after hemp was made legal in the United States, federal drug authorities have updated their guidance to remind law enforcement that hemp is no longer a controlled substance.
A notice posted Monday by the U.S. Drug Enforcement Administration (DEA) cited the 2018 Farm Bill in noting that “certain forms of cannabis no longer require DEA registration to grow or manufacture.”
The agency went on to say that “hemp, including hemp plants and cannabidiol (CBD) preparations at or below the 0.3 percent delta-9 THC threshold is not a controlled substance.”
The DEA notice didn’t change the law or make hemp legal; that occurred last year.
But because the agency had yet to remind national law enforcement through its regular bulletins that hemp is legal, some hemp businesses found themselves fighting legal confusion about the plant’s status.
Attorneys who represent hemp clients told Hemp Industry Daily that the DEA statement is an overdue affirmation of cannabis legality.
The DEA also announced Monday that it will expand research on higher-THC varieties of cannabis classified as marijuana.
For Immediate Release
Feb. 13, 2019
Hemp legislation passes House Agriculture panel
FRANKFORT—Kentucky would expand its definition of industrial hemp to match language in the recently signed 2018 Farm Bill under legislation that today cleared the House Agriculture Committee.
House Bill 197, sponsored by House Agriculture Chair Rep. Richard Heath, R-Mayfield, would expand the definition to include the seeds of industrial hemp—formally called Cannabis sativa L.—derivatives, extracts, cannabinoids and isomers, among other components. That is the same definition found in the new U.S. Farm Bill, signed into law late last year, which removed hemp from the federal Controlled Substances Act.
Until last year hemp was outlawed nationwide since 1970 under the federal Controlled Substances Act. The 2014 federal Farm Bill, however, allowed states to engage in hemp research pilot programs under certain conditions. Industrial hemp has been grown in Kentucky since 2014 under a state-regulated research pilot program.
The committee today also approved House Concurrent Resolution 43, also sponsored by Rep. Heath, which asks social media sites Facebook and YouTube and web marketplaces eBay and Amazon to revisit policies that some users say interfere with marketing of hemp-based products.
“Multiple industrial hemp business owners across the Commonwealth encountered an unnecessary obstruction in marketing efforts when their key marketing platforms, such as Facebook, unpublished their web pages” even through production and marketing of industrial hemp and hemp products are legal, the resolution states.
If passed by both chambers and signed by the governor, HCR 43 would formally request that the four internet companies “quickly reexamine their policies relating to industrial hemp businesses.”
Both pieces of legislation now go to the full House for consideration.
JOIN US IN FRANKFORT! LOBBY DAY 2019!
FEBRUARY 6TH – ALL DAY!
2019 KY NORML Lobby Day and Rally in the Rotunda
Wednesday, February 6, 2019 at 9:30 AM – 3 PM EST
700 Capital Ave, Frankfort, KY 40601-3448, United States
KY4MM Tunnel Talk
Public · Hosted by Kentuckians for Medicinal Marijuana
Wednesday, February 6, 2019 at 10 AM – 2 PM EST
Capitol Annex 702 Capitol Ave, Frankfort, Kentucky 40601
Rally in the Rotunda
Public · Hosted by SB80 Support Page
Wednesday, February 6, 2019 at 1:30 PM – 2:30 PM EST
700 Capital Ave, Frankfort, KY 40601-3448, United States
The following BILLS are to be focused on this year:
SB 80 – Dan Seum – An Act relating to the regulation of cannabis and making an appropriation therefor.
(Adult Responsible Use Act)
Establish and create new sections of KRS Chapter 245 to define terms, allow possession, growth, use, processing, purchasing, transfer, and consumption of Cannabis; establish limits for transfer; allow for purchasing and manufacturing cannabis accessories; authorize activities and operation of retail stores…
HB 136 – Several Sponsors – An Act relating to medicinal marijuana and making an appropriation therefor
(Medical Cannabis Act)
…require the Department for Alcoholic Beverage and Cannabis Control to implement and regulate the medicinal marijuana program in Kentucky…
SB 82 – Jimmy Higdon – An Act relating to marijuana possession.
…make the penalty for possession of a personal use quantity of marijuana a prepayable non-criminal fine…
SB 83 / Perry B. Clark “Shauna’s Law” Relating to a drug free workplace / Seeks to mandate an appeals process for those employer’s who enforce drug-testing upon their employee’s which will address those persons who have been found in violation of the drug-free workplace policy by testing positive on random drug screens for legal Hemp products such as CBD. It would set aside that violation if proven that a legal product had been used.